Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 48 of 63975 entries
Sorted by: Best Match Show Resources per page
A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus.

Experimental and therapeutic medicine

Quan H, Zhang H, Wei W, Fang T, Chen D, Chen K.
PMID: 28912879
Exp Ther Med. 2017 Oct;14(4):3279-3287. doi: 10.3892/etm.2017.4863. Epub 2017 Aug 02.

The aim of the present study was to explore the effects of various combinations of exenatide, metformin (MET) and biphasic insulin aspart 30 (BIA30) on type 2 diabetes mellitus (T2DM). Two hundred overweight or obese patients newly diagnosed with...

Cite
Quan H, Zhang H, Wei W, et al. A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus. Exp Ther Med. 2017;14(4):3279-3287doi: 10.3892/etm.2017.4863.
Quan, H., Zhang, H., Wei, W., Fang, T., Chen, D., & Chen, K. (2017). A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus. Experimental and therapeutic medicine, 14(4), 3279-3287. https://doi.org/10.3892/etm.2017.4863
Quan, Huibiao, et al. "A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus." Experimental and therapeutic medicine vol. 14,4 (2017): 3279-3287. doi: https://doi.org/10.3892/etm.2017.4863
Quan H, Zhang H, Wei W, Fang T, Chen D, Chen K. A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus. Exp Ther Med. 2017 Oct;14(4):3279-3287. doi: 10.3892/etm.2017.4863. Epub 2017 Aug 02. PMID: 28912879; PMCID: PMC5585756.
Copy Download .nbib Format: NLM
One-Stage Anterolateral Debridement, Bone Grafting, and Internal Fixation for Treating Lumbosacral Tuberculosis.

Asian spine journal

Zhang T, Ma L, Lan X, Zhen P, Wang S, Li Z.
PMID: 28443176
Asian Spine J. 2017 Apr;11(2):305-313. doi: 10.4184/asj.2017.11.2.305. Epub 2017 Apr 12.

STUDY DESIGN: Retrospective case series.PURPOSE: To investigate the clinical efficacy and feasibility of one-stage anterolateral debridement, bone grafting, and internal fixation for treating lumbosacral tuberculosis.OVERVIEW OF LITERATURE: There has been no consensus regarding the optimal means of treating lumbosacral...

Cite
Zhang T, Ma L, Lan X, et al. One-Stage Anterolateral Debridement, Bone Grafting, and Internal Fixation for Treating Lumbosacral Tuberculosis. Asian Spine J. 2017;11(2):305-313doi: 10.4184/asj.2017.11.2.305.
Zhang, T., Ma, L., Lan, X., Zhen, P., Wang, S., & Li, Z. (2017). One-Stage Anterolateral Debridement, Bone Grafting, and Internal Fixation for Treating Lumbosacral Tuberculosis. Asian spine journal, 11(2), 305-313. https://doi.org/10.4184/asj.2017.11.2.305
Zhang, Tao, et al. "One-Stage Anterolateral Debridement, Bone Grafting, and Internal Fixation for Treating Lumbosacral Tuberculosis." Asian spine journal vol. 11,2 (2017): 305-313. doi: https://doi.org/10.4184/asj.2017.11.2.305
Zhang T, Ma L, Lan X, Zhen P, Wang S, Li Z. One-Stage Anterolateral Debridement, Bone Grafting, and Internal Fixation for Treating Lumbosacral Tuberculosis. Asian Spine J. 2017 Apr;11(2):305-313. doi: 10.4184/asj.2017.11.2.305. Epub 2017 Apr 12. PMID: 28443176; PMCID: PMC5401846.
Copy Download .nbib Format: NLM
Severe Thyrotoxicosis Secondary to Povidone-Iodine from Peritoneal Dialysis.

Case reports in endocrinology

Lithgow K, Symonds C.
PMID: 28912982
Case Rep Endocrinol. 2017;2017:2683120. doi: 10.1155/2017/2683120. Epub 2017 Aug 24.

A 73-year-old male on home peritoneal dialysis (PD) with recent diagnosis of atrial fibrillation presented with fatigue and dyspnea. Hyperthyroidism was diagnosed with TSH < 0.01 mIU/L and FT4 > 100 pmol/L. He had no personal or family history...

Cite
Lithgow K, Symonds C. Severe Thyrotoxicosis Secondary to Povidone-Iodine from Peritoneal Dialysis. Case Rep Endocrinol. 2017;2017:2683120doi: 10.1155/2017/2683120.
Lithgow, K., & Symonds, C. (2017). Severe Thyrotoxicosis Secondary to Povidone-Iodine from Peritoneal Dialysis. Case reports in endocrinology, 20172683120. https://doi.org/10.1155/2017/2683120
Lithgow, Kirstie, and Symonds, Christopher. "Severe Thyrotoxicosis Secondary to Povidone-Iodine from Peritoneal Dialysis." Case reports in endocrinology vol. 2017 (2017): 2683120. doi: https://doi.org/10.1155/2017/2683120
Lithgow K, Symonds C. Severe Thyrotoxicosis Secondary to Povidone-Iodine from Peritoneal Dialysis. Case Rep Endocrinol. 2017;2017:2683120. doi: 10.1155/2017/2683120. Epub 2017 Aug 24. PMID: 28912982; PMCID: PMC5587962.
Copy Download .nbib Format: NLM
Does the serum E2 level change following coasting treatment strategy to prevent ovarian hyperstimulation syndrome impact cycle outcomes during controlled ovarian hyperstimulation and in vitro fertilization procedure?.

Turkish journal of obstetrics and gynecology

Yumuşak ÖH, Kahyaoğlu S, Özgü Erdinç AS, Yılmaz S, Engin Üstün Y, Yılmaz N.
PMID: 28913010
Turk J Obstet Gynecol. 2014 Sep;11(3):159-164. doi: 10.4274/tjod.48751. Epub 2014 Sep 15.

OBJECTIVE: Ovarian hyperstimulation syndrome (OHSS) remains as a clinical problem for hyperresponder patients during controlled ovarian hyperstimulation and in vitro fertilization (COH-IVF) procedure. Herein, we aimed to evaluate the COH-IVF outcomes in hyperresponder patients managed with coasting treatment strategy...

Cite
Yumuşak ÖH, Kahyaoğlu S, Özgü Erdinç AS, et al. Does the serum E2 level change following coasting treatment strategy to prevent ovarian hyperstimulation syndrome impact cycle outcomes during controlled ovarian hyperstimulation and in vitro fertilization procedure?. Turk J Obstet Gynecol. 2014;11(3):159-164doi: 10.4274/tjod.48751.
Yumuşak, �. �. H., Kahyaoğlu, S., Özgü Erdinç, A. S., Yılmaz, S., Engin Üstün, Y., & Yılmaz, N. (2014). Does the serum E2 level change following coasting treatment strategy to prevent ovarian hyperstimulation syndrome impact cycle outcomes during controlled ovarian hyperstimulation and in vitro fertilization procedure?. Turkish journal of obstetrics and gynecology, 11(3), 159-164. https://doi.org/10.4274/tjod.48751
Yumuşak, Ömer Hamid, et al. "Does the serum E2 level change following coasting treatment strategy to prevent ovarian hyperstimulation syndrome impact cycle outcomes during controlled ovarian hyperstimulation and in vitro fertilization procedure?." Turkish journal of obstetrics and gynecology vol. 11,3 (2014): 159-164. doi: https://doi.org/10.4274/tjod.48751
Yumuşak ÖH, Kahyaoğlu S, Özgü Erdinç AS, Yılmaz S, Engin Üstün Y, Yılmaz N. Does the serum E2 level change following coasting treatment strategy to prevent ovarian hyperstimulation syndrome impact cycle outcomes during controlled ovarian hyperstimulation and in vitro fertilization procedure?. Turk J Obstet Gynecol. 2014 Sep;11(3):159-164. doi: 10.4274/tjod.48751. Epub 2014 Sep 15. PMID: 28913010; PMCID: PMC5558327.
Copy Download .nbib Format: NLM
Diabetes mellitus caused by secondary hemochromatosis after multiple blood transfusions in 2 patients with severe aplastic anemia.

Annals of pediatric endocrinology & metabolism

Kim HJ, Kim YM, Kang E, Lee BH, Choi JH, Yoo HW.
PMID: 28443261
Ann Pediatr Endocrinol Metab. 2017 Mar;22(1):60-64. doi: 10.6065/apem.2017.22.1.60. Epub 2017 Mar 31.

Hemochromatosis is an inherited or secondary disorder caused by excessive iron storage leading to multiple organ damage. We describe 2 patients with diabetes mellitus caused by hemochromatosis secondary to multiple blood transfusions due to severe aplastic anemia. Subject 1,...

Cite
Kim HJ, Kim YM, Kang E, et al. Diabetes mellitus caused by secondary hemochromatosis after multiple blood transfusions in 2 patients with severe aplastic anemia. Ann Pediatr Endocrinol Metab. 2017;22(1):60-64doi: 10.6065/apem.2017.22.1.60.
Kim, H. J., Kim, Y. M., Kang, E., Lee, B. H., Choi, J. H., & Yoo, H. W. (2017). Diabetes mellitus caused by secondary hemochromatosis after multiple blood transfusions in 2 patients with severe aplastic anemia. Annals of pediatric endocrinology & metabolism, 22(1), 60-64. https://doi.org/10.6065/apem.2017.22.1.60
Kim, Hyun Jin, et al. "Diabetes mellitus caused by secondary hemochromatosis after multiple blood transfusions in 2 patients with severe aplastic anemia." Annals of pediatric endocrinology & metabolism vol. 22,1 (2017): 60-64. doi: https://doi.org/10.6065/apem.2017.22.1.60
Kim HJ, Kim YM, Kang E, Lee BH, Choi JH, Yoo HW. Diabetes mellitus caused by secondary hemochromatosis after multiple blood transfusions in 2 patients with severe aplastic anemia. Ann Pediatr Endocrinol Metab. 2017 Mar;22(1):60-64. doi: 10.6065/apem.2017.22.1.60. Epub 2017 Mar 31. PMID: 28443261; PMCID: PMC5401825.
Copy Download .nbib Format: NLM
Role of osteocalcin, tumor necrosis factor-alpha and adiponectin in polycystic ovary syndrome patients with insulin resistance.

Turkish journal of obstetrics and gynecology

Erkan G, Tayyar AT, Açmaz G, Müderris İİ, Başkol G, Bayram F.
PMID: 28913143
Turk J Obstet Gynecol. 2017 Jun;14(2):89-93. doi: 10.4274/tjod.61224. Epub 2017 Jun 15.

OBJECTIVE: Insulin resistance (IR) seems to be the main pathogenic factor in polycystic ovary syndrome (PCOS). Adiponectin and tumor necrosis factor-alpha (TNF-α) are important in IR. The aim of this study was to evaluate the correlations of osteocalcin, adiponectin,...

Cite
Erkan G, Tayyar AT, Açmaz G, et al. Role of osteocalcin, tumor necrosis factor-alpha and adiponectin in polycystic ovary syndrome patients with insulin resistance. Turk J Obstet Gynecol. 2017;14(2):89-93doi: 10.4274/tjod.61224.
Erkan, G., Tayyar, A. T., Açmaz, G., Müderris, �. �. �. �., Başkol, G., & Bayram, F. (2017). Role of osteocalcin, tumor necrosis factor-alpha and adiponectin in polycystic ovary syndrome patients with insulin resistance. Turkish journal of obstetrics and gynecology, 14(2), 89-93. https://doi.org/10.4274/tjod.61224
Erkan, Gönül, et al. "Role of osteocalcin, tumor necrosis factor-alpha and adiponectin in polycystic ovary syndrome patients with insulin resistance." Turkish journal of obstetrics and gynecology vol. 14,2 (2017): 89-93. doi: https://doi.org/10.4274/tjod.61224
Erkan G, Tayyar AT, Açmaz G, Müderris İİ, Başkol G, Bayram F. Role of osteocalcin, tumor necrosis factor-alpha and adiponectin in polycystic ovary syndrome patients with insulin resistance. Turk J Obstet Gynecol. 2017 Jun;14(2):89-93. doi: 10.4274/tjod.61224. Epub 2017 Jun 15. PMID: 28913143; PMCID: PMC5558419.
Copy Download .nbib Format: NLM
GLUT1 expression in pediatric adrenocortical tumors: a promising candidate to predict clinical behavior.

Oncotarget

Pinheiro C, Granja S, Longatto-Filho A, Faria AM, Fragoso MCBV, Lovisolo SM, Bonatelli M, Costa RFA, Lerário AM, Almeida MQ, Baltazar F, Zerbini MCN.
PMID: 28969033
Oncotarget. 2017 Jul 10;8(38):63835-63845. doi: 10.18632/oncotarget.19135. eCollection 2017 Sep 08.

BACKGROUND: Discrimination between benign and malignant tumors is a challenging process in pediatric adrenocortical tumors. New insights in the metabolic profile of pediatric adrenocortical tumors may contribute to this distinction, predict prognosis, as well as identify new molecular targets...

Cite
Pinheiro C, Granja S, Longatto-Filho A, et al. GLUT1 expression in pediatric adrenocortical tumors: a promising candidate to predict clinical behavior. Oncotarget. 2017;8(38):63835-63845doi: 10.18632/oncotarget.19135.
Pinheiro, C., Granja, S., Longatto-Filho, A., Faria, A. M., Fragoso, M. C. B. V., Lovisolo, S. M., Bonatelli, M., Costa, R. F. A., Lerário, A. M., Almeida, M. Q., Baltazar, F., & Zerbini, M. C. N. (2017). GLUT1 expression in pediatric adrenocortical tumors: a promising candidate to predict clinical behavior. Oncotarget, 8(38), 63835-63845. https://doi.org/10.18632/oncotarget.19135
Pinheiro, Céline, et al. "GLUT1 expression in pediatric adrenocortical tumors: a promising candidate to predict clinical behavior." Oncotarget vol. 8,38 (2017): 63835-63845. doi: https://doi.org/10.18632/oncotarget.19135
Pinheiro C, Granja S, Longatto-Filho A, Faria AM, Fragoso MCBV, Lovisolo SM, Bonatelli M, Costa RFA, Lerário AM, Almeida MQ, Baltazar F, Zerbini MCN. GLUT1 expression in pediatric adrenocortical tumors: a promising candidate to predict clinical behavior. Oncotarget. 2017 Jul 10;8(38):63835-63845. doi: 10.18632/oncotarget.19135. eCollection 2017 Sep 08. PMID: 28969033; PMCID: PMC5609965.
Copy Download .nbib Format: NLM
A global perspective on hypertension: a Lancet Commission.

Lancet (London, England)

Olsen MH, Spencer S.
PMID: 26334143
Lancet. 2015 Aug 15;386(9994):637-8. doi: 10.1016/S0140-6736(15)61178-3.

No abstract available.

Cite
Olsen MH, Spencer S. A global perspective on hypertension: a Lancet Commission. Lancet. 2015;386(9994):637-8doi: 10.1016/S0140-6736(15)61178-3.
Olsen, M. H., & Spencer, S. (2015). A global perspective on hypertension: a Lancet Commission. Lancet (London, England), 386(9994), 637-8. https://doi.org/10.1016/S0140-6736(15)61178-3
Olsen, Michael Hecht, and Spencer, Stuart. "A global perspective on hypertension: a Lancet Commission." Lancet (London, England) vol. 386,9994 (2015): 637-8. doi: https://doi.org/10.1016/S0140-6736(15)61178-3
Olsen MH, Spencer S. A global perspective on hypertension: a Lancet Commission. Lancet. 2015 Aug 15;386(9994):637-8. doi: 10.1016/S0140-6736(15)61178-3. PMID: 26334143.
Copy Download .nbib Format: NLM
Effect of Tongxinluo on Nephrin Expression via Inhibition of Notch1/Snail Pathway in Diabetic Rats.

Evidence-based complementary and alternative medicine : eCAM

Cui F, Zou D, Gao Y, Zhang N, Wang J, Xu L, Geng J, Li J, Zhou S, Wang X.
PMID: 26417374
Evid Based Complement Alternat Med. 2015;2015:424193. doi: 10.1155/2015/424193. Epub 2015 Aug 31.

Podocyte injury is an important mechanism of diabetic nephropathy (DN). Accumulating evidence suggests that nephrin expression is decreased in podocyte in DN. Moreover, it has been demonstrated that tongxinluo (TXL) can ameliorate renal structure disruption and dysfunction in DN....

Cite
Cui F, Zou D, Gao Y, et al. Effect of Tongxinluo on Nephrin Expression via Inhibition of Notch1/Snail Pathway in Diabetic Rats. Evid Based Complement Alternat Med. 2015;2015:424193doi: 10.1155/2015/424193.
Cui, F., Zou, D., Gao, Y., Zhang, N., Wang, J., Xu, L., Geng, J., Li, J., Zhou, S., & Wang, X. (2015). Effect of Tongxinluo on Nephrin Expression via Inhibition of Notch1/Snail Pathway in Diabetic Rats. Evidence-based complementary and alternative medicine : eCAM, 2015424193. https://doi.org/10.1155/2015/424193
Cui, Fangqiang, et al. "Effect of Tongxinluo on Nephrin Expression via Inhibition of Notch1/Snail Pathway in Diabetic Rats." Evidence-based complementary and alternative medicine : eCAM vol. 2015 (2015): 424193. doi: https://doi.org/10.1155/2015/424193
Cui F, Zou D, Gao Y, Zhang N, Wang J, Xu L, Geng J, Li J, Zhou S, Wang X. Effect of Tongxinluo on Nephrin Expression via Inhibition of Notch1/Snail Pathway in Diabetic Rats. Evid Based Complement Alternat Med. 2015;2015:424193. doi: 10.1155/2015/424193. Epub 2015 Aug 31. PMID: 26417374; PMCID: PMC4568378.
Copy Download .nbib Format: NLM
Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling.

Immunity, inflammation and disease

Martin P, Palmer G, Rodriguez E, Woldt E, Mean I, James RW, Smith DE, Kwak BR, Gabay C.
PMID: 26417439
Immun Inflamm Dis. 2015 Sep;3(3):239-46. doi: 10.1002/iid3.62. Epub 2015 May 10.

Interleukin (IL)-33 is a cytokine of the IL-1 family, which signals through the ST2 receptor. Previous work demonstrated that the systemic administration of recombinant IL-33 reduces the development of atherosclerosis in apolipoprotein E-deficient (ApoE(-/-)) mice by inducing a Th1-to-Th2...

Cite
Martin P, Palmer G, Rodriguez E, et al. Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling. Immun Inflamm Dis. 2015;3(3):239-46doi: 10.1002/iid3.62.
Martin, P., Palmer, G., Rodriguez, E., Woldt, E., Mean, I., James, R. W., Smith, D. E., Kwak, B. R., & Gabay, C. (2015). Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling. Immunity, inflammation and disease, 3(3), 239-46. https://doi.org/10.1002/iid3.62
Martin, Praxedis, et al. "Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling." Immunity, inflammation and disease vol. 3,3 (2015): 239-46. doi: https://doi.org/10.1002/iid3.62
Martin P, Palmer G, Rodriguez E, Woldt E, Mean I, James RW, Smith DE, Kwak BR, Gabay C. Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling. Immun Inflamm Dis. 2015 Sep;3(3):239-46. doi: 10.1002/iid3.62. Epub 2015 May 10. PMID: 26417439; PMCID: PMC4578523.
Copy Download .nbib Format: NLM
Plasma Levels of Free Thyroxine and Risk of Major Bleeding in Bariatric Surgery.

European thyroid journal

Elbers LP, Boon HA, Moes MI, van Zaane B, Brandjes DP, Fliers E, Büller HR, Cannegieter S, Gerdes VE.
PMID: 27493889
Eur Thyroid J. 2016 Jul;5(2):139-44. doi: 10.1159/000446431. Epub 2016 Jun 14.

BACKGROUND: In a recent study of patients using vitamin K antagonists, those with low free thyroxin (FT4) levels within the normal range had a 3- to 5-fold increased risk of major bleeding. We tested the hypothesis that low levels...

Cite
Elbers LP, Boon HA, Moes MI, et al. Plasma Levels of Free Thyroxine and Risk of Major Bleeding in Bariatric Surgery. Eur Thyroid J. 2016;5(2):139-44doi: 10.1159/000446431.
Elbers, L. P., Boon, H. A., Moes, M. I., van Zaane, B., Brandjes, D. P., Fliers, E., Büller, H. R., Cannegieter, S., & Gerdes, V. E. (2016). Plasma Levels of Free Thyroxine and Risk of Major Bleeding in Bariatric Surgery. European thyroid journal, 5(2), 139-44. https://doi.org/10.1159/000446431
Elbers, Laura P B, et al. "Plasma Levels of Free Thyroxine and Risk of Major Bleeding in Bariatric Surgery." European thyroid journal vol. 5,2 (2016): 139-44. doi: https://doi.org/10.1159/000446431
Elbers LP, Boon HA, Moes MI, van Zaane B, Brandjes DP, Fliers E, Büller HR, Cannegieter S, Gerdes VE. Plasma Levels of Free Thyroxine and Risk of Major Bleeding in Bariatric Surgery. Eur Thyroid J. 2016 Jul;5(2):139-44. doi: 10.1159/000446431. Epub 2016 Jun 14. PMID: 27493889; PMCID: PMC4949359.
Copy Download .nbib Format: NLM
Evaluation of three read-depth based CNV detection tools using whole-exome sequencing data.

Molecular cytogenetics

Yao R, Zhang C, Yu T, Li N, Hu X, Wang X, Wang J, Shen Y.
PMID: 28852425
Mol Cytogenet. 2017 Aug 23;10:30. doi: 10.1186/s13039-017-0333-5. eCollection 2017.

BACKGROUND: Whole exome sequencing (WES) has been widely accepted as a robust and cost-effective approach for clinical genetic testing of small sequence variants. Detection of copy number variants (CNV) within WES data have become possible through the development of...

Cite
Yao R, Zhang C, Yu T, et al. Evaluation of three read-depth based CNV detection tools using whole-exome sequencing data. Mol Cytogenet. 2017;10:30doi: 10.1186/s13039-017-0333-5.
Yao, R., Zhang, C., Yu, T., Li, N., Hu, X., Wang, X., Wang, J., & Shen, Y. (2017). Evaluation of three read-depth based CNV detection tools using whole-exome sequencing data. Molecular cytogenetics, 1030. https://doi.org/10.1186/s13039-017-0333-5
Yao, Ruen, et al. "Evaluation of three read-depth based CNV detection tools using whole-exome sequencing data." Molecular cytogenetics vol. 10 (2017): 30. doi: https://doi.org/10.1186/s13039-017-0333-5
Yao R, Zhang C, Yu T, Li N, Hu X, Wang X, Wang J, Shen Y. Evaluation of three read-depth based CNV detection tools using whole-exome sequencing data. Mol Cytogenet. 2017 Aug 23;10:30. doi: 10.1186/s13039-017-0333-5. eCollection 2017. PMID: 28852425; PMCID: PMC5569469.
Copy Download .nbib Format: NLM
Showing 37 to 48 of 63975 entries